Search for: "Allergan, Inc."
Results 321 - 340
of 385
Sorted by Relevance
|
Sort by Date
5 Sep 2013, 12:24 pm
Allergan, Inc., 863 F. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
14 Oct 2018, 9:44 am
However, this point should not have been considered in the first place.As pointed out by the Singapore High Court in Allergan, Inc and anor v Ferlandz Nutra Pte Ltd, the registration of a mark “in block capital letters covers the use of the word in every font or style possible” (at [44]). [read post]
17 Jan 2014, 5:02 am
Allergan, Inc., C.A. [read post]
5 Jul 2015, 12:59 pm
AstraZeneca, Pfizer and Allergan were other big spenders in the category of general payments. [read post]
26 Dec 2017, 5:00 am
Massey, Pyott (Allergan), and Westmoreland (a Seventh Circuit case involving Baxter International).The case is No. 12151-VCG. [read post]
29 May 2014, 3:44 am
Now Francis Pileggi of Eckert Seamans blogs this news: A proposed new addition and amendments to the Delaware General Corporation Law would limit the impact of a recent Delaware Supreme Court decision in ATP Tours, Inc. v. [read post]
24 Aug 2011, 12:33 am
The lobbying push for a PTE (FDA Law Blog) US: Generics fees: A fantastic opportunity (profitability through simplicity) USPTO announces agenda for next BCP customer partnership meeting (Patent Docs) US: GOP candidates unified in opposition to embryonic cell research (Patent Docs) US: District Court Massachusetts: Method of detecting fetal down syndrome passes muster under Bilski‘s machine-or-transformation test: PerkinElmer, Inc., et. al. v. [read post]
15 Mar 2012, 8:30 am
Unlimited Recharge Inc., questions the doctrine's ongoing viability, albeit in a dicta footnote. [read post]
27 Oct 2010, 8:57 am
" AP reports, Topping the list was specialty drugmaker Allergan Inc. which paid out $600 million to settle allegations that it marketed the anti-wrinkle injection Botox for unapproved uses. [read post]
16 Aug 2011, 5:35 pm
Irell has represented some of the largest and most successful companies in the world in intellectual property fights with other corporate giants including Research in Motion, TiVo, and Allergan, Inc. [read post]
16 Feb 2018, 2:06 pm
Inc. [read post]
8 Dec 2010, 2:20 am
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and… [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
3 Jan 2018, 5:10 am
On the heels of the Ericsson decision, further briefing on the waiver issue was recently authorized in Mylan Pharmaceuticals Inc., et al. v. [read post]
8 Oct 2014, 6:29 am
Allergan, Inc. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
27 Oct 2010, 8:57 am
" AP reports, Topping the list was specialty drugmaker Allergan Inc. which paid out $600 million to settle allegations that it marketed the anti-wrinkle injection Botox for unapproved uses. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
10 May 2016, 10:45 am
Allergan, Inc., -- Cal. [read post]
